Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS
NANTONG, China, Aug. 6, 2026 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics, today announced the completion of patient enrollment and initial dosing across all cohorts in its...
Acer Announces Q2'26 Net Income at NT$2.17 Billion, Highest Quarter Post Pandemic; Up 100.2% Year-on-year
TAIPEI, Aug. 6, 2026 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated financial results for the second quarter and first half of 2026. Reflecting the continued progress of its multiple business engines strategy, Acer delivered the...
Quant Hedge Fund Alpha2Fund Announces 100 Million Yuan Proprietary Investment as 25 Hedge Funds Join July Self-Investment Wave
BEIJING, Aug. 6, 2026 /PRNewswire/ -- Ningbo Alpha2Fund Investment Management Partnership Enterprise (Limited Partnership) — a well‑known quantitative private fund manager (hereafter referred to as Alpha2Fund) announced on July 19 that based on its...
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China
SAN FRANCISCO and SUZHOU, China, Aug. 6, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
KPM Analytics Announces In-Line NIR Sensors Specifically Designed for Food Processing
Sensors measure moisture, fat/oil, color, and temperature in-line for improved process control. WESTBOROUGH, Mass., Aug. 5, 2026 /PRNewswire/ -- Increasingly, food processors are striving for "zero-defects" by measuring as many quality parameters as...
Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product
Alteogen grants exclusive rights to develop and commercialize a subcutaneous biologic product using Hybrozyme™-based hyaluronidase ALT-B4 Alteogen is eligible to receive up to US$365 million, including an upfront payment and development, regulatory...
NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from...
So-Young Announces Appointment of Chief Financial Officer
BEIJING, Aug. 5, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that...
Elong Power Holding Limited Announces Closing of US$1.38 Million Public Offering
BEIJING, Aug. 5, 2026 /PRNewswire/ -- Elong Power Holding Limited (Nasdaq: ELPW) ("Elong Power" or the "Company"), a comprehensive provider dedicated to the R&D, sales and scenario-oriented system solutions of lithium-ion battery energy storage...
SU Group Holdings Limited Announces Reverse Stock Split
Reverse Stock-Split to be effective on August 6, 2026 HONG KONG, August 4, 2026 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services company in Hong Kong, today...